Verweij J - Search Results

1

Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancer.

Bontenbal M, Planting AS, Verweij J, de Wit R, Kruit WH, Stoter G, Klijn JG. Bontenbal M, et al. Among authors: verweij j. Breast Cancer Res Treat. 1995 May;34(2):185-9. doi: 10.1007/BF00665790. Breast Cancer Res Treat. 1995. PMID: 7647335 Free article. Clinical Trial.

2

A dose-finding study of miltefosine (hexadecylphosphocholine) in patients with metastatic solid tumours.

Verweij J, Planting A, van der Burg M, Stoter G. Verweij J, et al. J Cancer Res Clin Oncol. 1992;118(8):606-8. doi: 10.1007/BF01211805. J Cancer Res Clin Oncol. 1992. PMID: 1325463 Free article. Clinical Trial.

3

Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancer.

Bontenbal M, Planting AS, Rodenburg CJ, Dees A, Verweij J, Bartels CC, Alexieva-Figusch J, van Putten WL, Klijn JG. Bontenbal M, et al. Among authors: verweij j. Breast Cancer Res Treat. 1992;21(2):133-8. doi: 10.1007/BF01836959. Breast Cancer Res Treat. 1992. PMID: 1627816 Free article. Clinical Trial.

4

Phase II study of ACNU as first-line treatment in advanced colorectal cancer.

Planting A, Hoff A, van der Burg M, Verweij J, Stoter G. Planting A, et al. Among authors: verweij j. Ann Oncol. 1991 Nov-Dec;2(10):767-8. doi: 10.1093/oxfordjournals.annonc.a057862. Ann Oncol. 1991. PMID: 1801885 Free article. Clinical Trial.

5

Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: a phase II study including endocrine effects.

Klijn JG, Hoff AM, Planting AS, Verweij J, Kok T, Lamberts SW, Portengen H, Foekens JA. Klijn JG, et al. Among authors: verweij j. Br J Cancer. 1990 Oct;62(4):627-30. doi: 10.1038/bjc.1990.343. Br J Cancer. 1990. PMID: 1977468 Free PMC article.

6

Mitomycin C is an inactive drug in the third-line treatment of hormone and chemotherapy refractory breast cancer.

Dees A, Verweij J, van Putten WL, Stoter G. Dees A, et al. Among authors: verweij j. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1343-7. doi: 10.1016/0277-5379(87)90118-0. Eur J Cancer Clin Oncol. 1987. PMID: 3119346

7

Phase II study on oral N-methylformamide in metastatic colorectal cancer.

Planting AS, Klijn JG, Verweij J, Stoter G. Planting AS, et al. Among authors: verweij j. Cancer Treat Rep. 1987 Dec;71(12):1293-4. Cancer Treat Rep. 1987. PMID: 3690540 No abstract available.

8

Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site.

van der Gaast A, Verweij J, Planting AS, Hop WC, Stoter G. van der Gaast A, et al. Among authors: verweij j. J Clin Oncol. 1995 Jul;13(7):1720-5. doi: 10.1200/JCO.1995.13.7.1720. J Clin Oncol. 1995. PMID: 7541451 Clinical Trial.

9

Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumors.

Planting AS, van der Burg ME, de Boer-Dennert M, Stoter G, Verweij J. Planting AS, et al. Among authors: verweij j. Ann Oncol. 1995 Feb;6(2):190-2. doi: 10.1093/oxfordjournals.annonc.a059117. Ann Oncol. 1995. PMID: 7786826 Free article. Clinical Trial.

10

Phase II study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy.

de Wit R, van der Burg ME, van den Gaast A, Logmans A, Stoter G, Verweij J. de Wit R, et al. Among authors: verweij j. Ann Oncol. 1994 Sep;5(7):656-7. doi: 10.1093/oxfordjournals.annonc.a058942. Ann Oncol. 1994. PMID: 7993845 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

927 results

Search Page

Filters